Website News and Research

RSS

FDA's ODAC to review Affymax peginesatide NDA for treatment of CKD-associated anemia

Affymax, Inc. today announced that the U.S. Food and Drug Administration's (FDA) Oncologic Drugs Advisory Committee (ODAC) will review the New Drug Application (NDA) for peginesatide proposed for the treatment of anemia associated with chronic kidney disease (CKD) in adult patients on dialysis on December 7, 2011 during the afternoon session.

24 Oct 2011

$IOF report predicts major increase in osteoporosis fractures in the Middle East and Africa$

IOF report predicts major increase in osteoporosis fractures in the Middle East and Africa

A new audit report issued today by the International Osteoporosis Foundation (IOF) shows that osteoporosis is a serious and growing problem throughout the Middle East and parts of Africa.

22 Oct 2011

New sleepwear now available for post-surgery breast cancer patients

For breast cancer patients, surgery is often the first line of treatment. Following surgery, patients must deal not only with the healing process, but also with lasting after effects such as scarring, skin sensitivity and body asymmetry. A new line of sleepwear now available to breast cancer survivors is the result of an ongoing research partnership between Ryerson University and Princess Margaret Hospital that examines how the side effects of surgery and treatment affect women's physical comfort, confidence and sexuality.

22 Oct 2011

Effective ways to reduce risk of vaginal yeast infection

Vaginal thrush is one of the most popular topics on NHS Choices website. This common yeast infection affects around 75% (three-quarters) of women at some point. Up to half of these will have thrush more than once.

21 Oct 2011

AAWC, ACES to offer online educational opportunity for wound care experts

The Association for the Advancement of Wound Care (AAWC) announces the Virtual Wound - an exciting and unique online educational opportunity for AAWC members through a partnership with Applied Computer Education Services, Inc.

19 Oct 2011

Commercialization strategies for next-generation medicines

The Center for Biotechnology at Stony Brook University, in collaboration with Demy-Colton Life Science Advisors, and key opinion leaders from the biotech and biopharmaceutical industries, academia, medical research foundations, and investment community, has organized a two-day event to forge partnerships to accelerate the development of new treatments for some of the world's most devastating diseases affecting millions.

18 Oct 2011

PFF establishes Research Fund to Cure Pulmonary Fibrosis

The Pulmonary Fibrosis Foundation (PFF) announced today that it has established the PFF Research Fund to Cure Pulmonary Fibrosis, a fund created to support research that will assist in the development of successful therapies for pulmonary fibrosis.

18 Oct 2011

California Medical Association with 35,000 doctors in tow wants to legalize and regulate marijuana

Along with other supporters of legalizing marijuana, now there is the California Medical Association. The CMA that includes 35,000 doctors has adopted an official policy that recommends the legalization and regulation of cannabis. California Medical Association adopted the new stance at its annual meeting Friday in Anaheim.

17 Oct 2011

Majority of parents like doctor recommended websites

While parents commonly use the Internet to learn about pediatric health problems, little is known about how often they seek out this information, and how they use it prior to seeking medical care.

15 Oct 2011

Blue Shield of Calif. adds additional $283 million to policyholder 'giveback'

Blue Shield of California says it will give customers in the state a $283-million credit on their insurance premiums, saying it is fulfilling a promise to return money to policyholders when its net income exceeds 2 percent of revenue.

15 Oct 2011

QUT program assists cancer survivors in self-managing their health, emotional concerns

The Queensland University of Technology (QUT ) School of Nursing and Midwifery, in Brisbane, Australia, has designed a program to assist cancer survivors in self-managing their health and emotional concerns.

15 Oct 2011

CooperVision's voluntary recall of Avaira Toric contact lenses continues

In full cooperation with the United States Food and Drug Administration, CooperVision, Inc. is continuing to work with the FDA, distributors, customers, eye care practitioners and lens wearers to complete the worldwide recall initiated on August 19, 2011 on certain lots of Avaira Toric contact lenses.

14 Oct 2011

Researchers demonstrate that iPS stem cells may be used for gene therapy

This research, published on Oct. 12 on the Nature review website, provides evidence of a major concept could pave the way for the future use of these stem cells to treat humans, through perspective gene therapies.

14 Oct 2011

Conrad: Efforts to repeal health law via budget procedures would be 'misusing' the rules

Also in the news, media outlets report on a range of issues related to the health law's implementation, including accountable care organizations, essential benefits and an HHS warning about a fake website related to the measure's pre-existing condition insurance plan.

14 Oct 2011

HHS: Pica eating disorder hospitalizations on the rise in the U.S.

An unusual eating disorder that many people have never even heard of is attracting attention because of a recent government study that indicated the disorder is on the rise in the United States.

13 Oct 2011

Over 6,000 Australians joined ‘Weigh it Up Australia’

Weigh it Up Australia re-launched its FREE online healthy living program last Sunday with more than 6,000 Australians signing up to join the program within the first three days. Weigh it Up’s new website offers new and existing members access to more experts and 2 new ways to participate in its healthy living program.

11 Oct 2011

FDA clears Cardium's new Excellagen topical gel for diabetic foot ulcers

Cardium Therapeutics announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market and sell the Company's new Excellagen professional-use, sterile, syringe-based advanced wound care product for the management of diabetic foot ulcers and other dermal wounds.

11 Oct 2011

Cardium's Excellagen topical gel for diabetic foot ulcers receives FDA 510(k) clearance

Cardium Therapeutics announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market and sell the Company's new Excellagen™ professional-use, sterile, syringe-based advanced wound care product for the management of diabetic foot ulcers and other dermal wounds.

10 Oct 2011

Roundup: Brewer defends request for exchange funds; Calif. governor signs maternity benefit bill

Republican Gov. Jan Brewer of Arizona said Thursday that despite opposition from legislators from within her own party, she's seeking money from the federal government to implement a key part of the health care overhaul she opposes in order to prepare her state in case the law is upheld.

7 Oct 2011

CEL-SCI closes previously announced registered direct offering

CEL-SCI Corporation announced today that it has closed its previously announced registered direct offering for the sale of (i) 13,333,334 shares of its common stock at a price per share of $0.30 and (ii) warrants to purchase up to 12,000,000 shares of CEL-SCI Corporation's common stock at a purchase price of $0.40. The warrants may be exercised at any time prior to October 6, 2014.

7 Oct 2011

Website News and Research

FDA's ODAC to review Affymax peginesatide NDA for treatment of CKD-associated anemia

IOF report predicts major increase in osteoporosis fractures in the Middle East and Africa

New sleepwear now available for post-surgery breast cancer patients

Effective ways to reduce risk of vaginal yeast infection

AAWC, ACES to offer online educational opportunity for wound care experts

Commercialization strategies for next-generation medicines

PFF establishes Research Fund to Cure Pulmonary Fibrosis

California Medical Association with 35,000 doctors in tow wants to legalize and regulate marijuana

Majority of parents like doctor recommended websites

Blue Shield of Calif. adds additional $283 million to policyholder 'giveback'

QUT program assists cancer survivors in self-managing their health, emotional concerns

CooperVision's voluntary recall of Avaira Toric contact lenses continues

Researchers demonstrate that iPS stem cells may be used for gene therapy

Conrad: Efforts to repeal health law via budget procedures would be 'misusing' the rules

HHS: Pica eating disorder hospitalizations on the rise in the U.S.

Over 6,000 Australians joined ‘Weigh it Up Australia’

FDA clears Cardium's new Excellagen topical gel for diabetic foot ulcers

Cardium's Excellagen topical gel for diabetic foot ulcers receives FDA 510(k) clearance

Roundup: Brewer defends request for exchange funds; Calif. governor signs maternity benefit bill

CEL-SCI closes previously announced registered direct offering

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News